Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treg-depleted autologous lymphocytes in metastatic colorectal cancer
NCT00986518Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2012
- Primary completion
- Feb 2013
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous regulatory T cell-depleted lymphocytes in colorectal cancer (CRC), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Tumor size of hepatic and/or lung metastases at Month 9. Started Oct 2012; status: completed.
02
Drugs
autologous regulatory T cell-depleted lymphocytes
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00986518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00986518.